Please assess the completion status of the following clinical trial:

Trial Title: Safety and Efficacy of Two Artificial Tears in Dry Eye Subjects

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: None
- Time Perspective: None
- Masking: DOUBLE
- Phase: None
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Current use of an artificial tear at least twice daily, for at least three months prior to Day 1, on average~* Ability/agreement to wear habitual correction (glasses) during study period~Exclusion Criteria:~* Known allergy or sensitivity to the study product(s) or its components~* Anticipate contact lens wear during the study, or subject has worn contact lenses in the last six months~* Chronic use of systemic medications which may affect a dry eye condition~* Active ocular allergy or infection~* Use of Restasis® or other topical cyclosporine products within 3 months prior to Day 1~* Current use of any topical ophthalmic medications, have used within 2 weeks prior to Day 1, or are likely to use during study.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Glycerin and Polysorbate 80 based artificial tear (Type: ACTIVE_COMPARATOR): Glycerin and Polysorbate 80 based artificial tear
- Artificial Tears Formulation 1 (Type: EXPERIMENTAL): Formulation 1: Carboxymethylcellulose sodium, glycerin and Polysorbate 80, based artificial tear
- Artificial Tears Formulation 2 (Type: EXPERIMENTAL): Formulation 2: Carboxymethylcellulose sodium, glycerin, and Polysorbate 80 based artificial tear

Based on this trial design, predict the completion outcome and termination type (if applicable).